• Board of Directors

    Board of Directors

    Board of Directors

    The board of directors at
    Apollo Endosurgery Inc.

  • Board of Directors





    Board of Directors

    The board of directors at Apollo Endosurgery Inc.


Rich Meelia

Chairman of the Board

Mr. Meelia has served as the Chairman of the board of directors of Apollo since 2012. From July 2007 until his retirement in July 2011, Mr. Meelia served as Chairman, President, and Chief Executive Officer of Covidien plc following its separation from Tyco International in June 2007. From January 2006 through the separation, Mr. Meelia was the Chief Executive Officer of Tyco Healthcare and from 1995 through the separation, Mr. Meelia was also the President of Tyco Healthcare. Mr. Meelia joined Kendall Healthcare Products Company, the foundation of both the Tyco Healthcare Business and Covidien, as Group President in 1991. He became President of Tyco Healthcare in 1995. Mr. Meelia is a member of the board of directors of Haemonetics Corporation, for which he serves as Chairman, and ConformMIS, Inc. Mr. Meelia holds a B.A business from Saint Anselm College and an M.B.A. from Boston College. Apollo believes Mr. Meelia’s qualifications to serve on the board of directors include his extensive industry knowledge and experience as a chief executive within the medical device industry and his public company governance expertise.

Todd Newton

Chief Executive Officer, Director

Mr. Newton has served as Chief Executive Officer and as a member of the board of directors of Apollo since 2014. From 2009 to 2014, Mr. Newton served as Executive Vice President, Chief Financial Officer and Chief Operating Officer at ArthroCare Corporation, a medical device company. Prior to his leadership at ArthroCare, Mr. Newton served in a number of executive officer roles, including President and Chief Executive Officer, at Synenco Energy, Inc., a Canadian oilsands company. From 1994 to 2004, Mr. Newton was a Partner at Deloitte & Touche LLP. Mr. Newton holds a B.B.A. in accounting from The University of Texas at San Antonio.

Matthew S. Crawford

Director

Mr. Crawford has served as a member of the board of directors of Apollo since 2006. In 2003, Mr. Crawford founded PTV Healthcare Capital, a venture capital and private equity firm specializing in the healthcare and life sciences industries, and has served since its founding as Managing Director. Prior to PTV, Mr. Crawford was a Partner at Academy Funds, a venture capital firm based in Research Triangle Park, North Carolina. He has served on the board of directors of more than 20 healthcare companies and currently serves on the board of directors of several private companies. Mr. Crawford holds a B.A. in history and an M.B.A. from Wake Forest University. Apollo believes Mr. Crawford’s qualifications to serve on the board of directors include his extensive experience in venture capital and the medical technologies industry.

Bruce Robertson, Ph.D.

Director

Dr. Robertson has served as a member of the board of directors of Apollo since 2007. Since 2005, Dr. Robertson has served as Managing Director of H.I.G. Capital, LLC, a global private equity and investment firm. From 2003 to 2005, Dr. Robertson served as Managing Director at Toucan Capital, an early-stage venture capital fund focusing on life science investments. Mr. Robertson holds a B.S.E. in chemical engineering and B.A. in mathematics from the University of Pennsylvania, an M.B.A. from Harvard Business School, and a Ph.D. in chemical engineering from the University of Delaware. Apollo believes Dr. Robertson’s qualifications to serve on the board of directors include his medical and research backgrounds and his extensive experience in venture capital and the medical technologies industry.

Jack Nielsen

Director

Mr. Nielsen has served as a member of the board of directors of Apollo since 2012. Since 2001, Mr. Nielsen has been employed by Novo A/S, the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation, which manages the foundation’s financial assets through investments in the life science industry, where he currently serves as a Senior Partner. From 2006 to 2012, Mr. Nielsen was employed as a Partner at Novo Ventures (US) Inc. in San Francisco, a wholly-owned subsidiary of Novo A/S. He is a member of the board of directors of two publicly listed companies, Reata Pharmaceuticals Inc. and Merus N.V. Mr. Nielsen holds a M.Sc. in chemical engineering from the Technical University of Denmark and an M.S. in management of technology from the Technical University of Denmark. Apollo believes Mr. Nielsen’s qualifications to serve on the board of directors include his extensive experience in venture capital and medical technologies industry.

John Creecy

Director

Mr. Creecy has served as a member of the board of directors of Apollo since 2011. Since 2011, Mr. Creecy has served as Chief Executive Officer and Director of Remeditex Ventures, LLC, a venture capital firm specializing in the life sciences, biomedical science and biotechnology industries. From 2001 to 2008, he served as President and Chief Executive Officer of Hunt Petroleum Corporation, an oil and gas exploration and production company, and from 1988 to 2000 as Chief Operating Officer of the Hodges Companies, Inc. Mr. Creecy holds a B.S. in accounting from Texas Tech University and an M.S. in tax from the University of North Texas. Mr. Creecy is also a former Certified Public Accountant. Apollo believes Mr. Creecy’s qualifications to serve on the board of directors include his extensive executive leadership experience.

R. Kent McGaughy, Jr.

Director

Mr. McGaughy has served as a member of the board of directors of Apollo since 2012. Since 2003, Mr. McGaughy has served as a Managing Director at CPMG, Inc. where he is a founding shareholder. Prior to joining CPMG’s predecessor, Cardinal Investment Company, in 1997, Mr. McGaughy worked in investment banking at Simmons & Company International. Mr. McGaughy is a member of the board of directors of one publicly listed company, Reata Pharmaceuticals Inc. and is a member of the board of directors of several private companies. He formerly served as a Director of Mandiant Corporation. He holds a B.A. in plan II (summa cum laude and member of Phi Beta Kappa) from The University of Texas and an M.B.A. from Harvard Business School. Apollo believes Mr. McGaughy’s qualifications to serve on the board of directors include his extensive leadership and executive experience in the financial services industry and his financial expertise.

Rick Anderson

Director

Mr. Anderson has served as a member of the board of directors of Apollo since 2013. Since 2008, Mr. Anderson has served as a Managing Director at PTV Healthcare Capital, a
venture capital and private equity firm specializing in the healthcare and life sciences industries. From 2005 to 2007, Mr. Anderson served as Company Group Chairman of Johnson & Johnson, and Worldwide Franchise Chairman of Cordis Corporation. From 2003 to 2005, Mr. Anderson served as President of Cordis Corporation. From 1997 to 2003, Mr. Anderson served in various other senior roles at Johnson & Johnson. Before joining Johnson & Johnson, Mr. Anderson served in senior leadership positions with other international healthcare and medical device companies. Mr. Anderson holds a B.B.A. in marketing from Mississippi State University. He served five years in the U.S. Army where he obtained the rank of captain. Apollo believes Mr. Anderson’s qualifications to serve on the board of directors include his extensive industry knowledge and experience and medical device commercial expertise.

Bill McClellan

Director

Mr. McClellan has served as a member of the board of directors of Apollo since 2014. From 2004 until his retirement in June 2016, Mr. McClellan served as the Executive Vice President & Chief Financial Officer of On-X Life Technologies, Inc., a medical device company that manufactures and sells heart valve prostheses and components and other cardiac surgery products and devices. Mr. McClellan holds a B.B.A in accounting from Abilene Christian University. He is a Certified Public Accountant. Apollo believes Mr. McClellan’s qualifications to sit on the board of directors include his financial and accounting experience and expertise as well as industry knowledge and experience.